Drug product
Irinotecan Hydrochloride Injection, USP, 40 mg/2 mL (20 mg/mL), 2 mL Single-Dose Vial, Rx Only, Distributed by: Areva Pharmaceuticals, Inc., Gerogetown, IN 47122, Made in India, NDC 59923-714-02.
D-0270-2021
Product summary
- Event
- Event 87363
- Status
- Terminated
- Classification
- Class II
- Quantity
- 3287 vials
- Official record key
drug-enforcement:D-0270-2021
Official wording
Reason: CGMP Deviations: based on a Warning Letter received by the manufacturer of the recalled product for inadequate out-of specification investigations, complaint and the investigation conclusions.
Code information: Lot 7S10022A, Exp Jan-21
Distribution pattern: Nationwide in the USA
Derived failure modes
-
Manufacturing or process control
CGMP Deviations